A Family Literacy Program for Latino Families
|ClinicalTrials.gov Identifier: NCT03941197|
Recruitment Status : Enrolling by invitation
First Posted : May 7, 2019
Last Update Posted : June 17, 2019
|Condition or disease||Intervention/treatment||Phase|
|Literacy||Behavioral: Ready and Healthy for Kindergarten Family Literacy program||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Ready and Healthy for Kindergarten- A Family Literacy Program for Latino Families|
|Actual Study Start Date :||May 28, 2019|
|Estimated Primary Completion Date :||September 2019|
|Estimated Study Completion Date :||December 2019|
Experimental: Ready and Healthy for Kindergarten Family Literacy Program
Ready and Healthy for Kindergarten Family Literacy Program- 8 weekly parent child workshops with text message reminders
Behavioral: Ready and Healthy for Kindergarten Family Literacy program
Participants will participate in 8 parent-child health-themed literacy workshops. Participants will receive 2-3 text messages per week for 8 weeks.
- Acceptability of Intervention Measure (AIM) Questionnaire [ Time Frame: After 8 week period. ]Acceptability will be measured using the Acceptability of Intervention Measure (AIM). The AIM consists of 4 questions that assess acceptability. Responses range from 1 (completely disagree) to 5 (completely agree). Scales are created by averaging responses.
- StimQ-Preschool survey [ Time Frame: At enrollment and after 8 week period. ]Parent reported measure of the cognitive home environment for children 5 months to 6 years to assess aspects of the home environment that affect child development.
- Alphabet knowledge assessment survey [ Time Frame: At enrollment and after 8 week period. ]Alphabet knowledge will be assessed.
- Sight word knowledge assessment survey [ Time Frame: At enrollment and after 8 week period. ]Sight word knowledge will be assessed
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03941197
|United States, New Jersey|
|Manuel E Jimenez|
|New Brunswick, New Jersey, United States, 08901|
|Principal Investigator:||Manuel E Jimenez, MD, MS||Rutgers Robert Wood Johnson Medical School|